Cargando…

Proton therapy versus photon radiation therapy for the management of a recurrent desmoid tumor of the right flank: a case report

Desmoid tumors are benign mesenchymal tumors with a strong tendency for local recurrence after surgery. Radiotherapy improves local control following incomplete resection, but nearby organs at risk may limit the dose to the target volume. The patient in this report presented with a recurrent desmoid...

Descripción completa

Detalles Bibliográficos
Autores principales: Kil, Whoon Jong, Nichols, R Charles, Kilkenny, John W, Huh, Soon Y, Ho, Meng Wei, Gupta, Pratibha, Marcus, Robert B, Indelicato, Daniel J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3542192/
https://www.ncbi.nlm.nih.gov/pubmed/23098082
http://dx.doi.org/10.1186/1748-717X-7-178
_version_ 1782255471354183680
author Kil, Whoon Jong
Nichols, R Charles
Kilkenny, John W
Huh, Soon Y
Ho, Meng Wei
Gupta, Pratibha
Marcus, Robert B
Indelicato, Daniel J
author_facet Kil, Whoon Jong
Nichols, R Charles
Kilkenny, John W
Huh, Soon Y
Ho, Meng Wei
Gupta, Pratibha
Marcus, Robert B
Indelicato, Daniel J
author_sort Kil, Whoon Jong
collection PubMed
description Desmoid tumors are benign mesenchymal tumors with a strong tendency for local recurrence after surgery. Radiotherapy improves local control following incomplete resection, but nearby organs at risk may limit the dose to the target volume. The patient in this report presented with a recurrent desmoid tumor of the right flank and underwent surgery with microscopically positive margins. Particular problems presented in this case included that the tumor bed was situated in close proximity to the liver and the right kidney and that the right kidney was responsible for 65% of the patient’s renal function. Intensity-modulated radiation therapy plans delivering 54 Gy necessarily exposed the right kidney to a V(18) of 98% and the liver to a V(30) of 55%. Proton therapy plans significantly reduced the right kidney V(18) to 32% and the liver V(30) to 28%. In light of this, the proton plan was utilized for treatment of this patient. Proton therapy was tolerated without gastrointestinal discomfort or other complaints. Twenty-four months after initiation of proton therapy, the patient is without clinical or radiographic evidence of disease recurrence. In this setting, the improved dose distribution associated with proton therapy allowed for curative treatment of a patient who arguably could not have been safely treated with intensity-modulated radiation therapy or other methods of conventional radiotherapy.
format Online
Article
Text
id pubmed-3542192
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-35421922013-01-11 Proton therapy versus photon radiation therapy for the management of a recurrent desmoid tumor of the right flank: a case report Kil, Whoon Jong Nichols, R Charles Kilkenny, John W Huh, Soon Y Ho, Meng Wei Gupta, Pratibha Marcus, Robert B Indelicato, Daniel J Radiat Oncol Case Report Desmoid tumors are benign mesenchymal tumors with a strong tendency for local recurrence after surgery. Radiotherapy improves local control following incomplete resection, but nearby organs at risk may limit the dose to the target volume. The patient in this report presented with a recurrent desmoid tumor of the right flank and underwent surgery with microscopically positive margins. Particular problems presented in this case included that the tumor bed was situated in close proximity to the liver and the right kidney and that the right kidney was responsible for 65% of the patient’s renal function. Intensity-modulated radiation therapy plans delivering 54 Gy necessarily exposed the right kidney to a V(18) of 98% and the liver to a V(30) of 55%. Proton therapy plans significantly reduced the right kidney V(18) to 32% and the liver V(30) to 28%. In light of this, the proton plan was utilized for treatment of this patient. Proton therapy was tolerated without gastrointestinal discomfort or other complaints. Twenty-four months after initiation of proton therapy, the patient is without clinical or radiographic evidence of disease recurrence. In this setting, the improved dose distribution associated with proton therapy allowed for curative treatment of a patient who arguably could not have been safely treated with intensity-modulated radiation therapy or other methods of conventional radiotherapy. BioMed Central 2012-10-26 /pmc/articles/PMC3542192/ /pubmed/23098082 http://dx.doi.org/10.1186/1748-717X-7-178 Text en Copyright ©2012 Kil et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Kil, Whoon Jong
Nichols, R Charles
Kilkenny, John W
Huh, Soon Y
Ho, Meng Wei
Gupta, Pratibha
Marcus, Robert B
Indelicato, Daniel J
Proton therapy versus photon radiation therapy for the management of a recurrent desmoid tumor of the right flank: a case report
title Proton therapy versus photon radiation therapy for the management of a recurrent desmoid tumor of the right flank: a case report
title_full Proton therapy versus photon radiation therapy for the management of a recurrent desmoid tumor of the right flank: a case report
title_fullStr Proton therapy versus photon radiation therapy for the management of a recurrent desmoid tumor of the right flank: a case report
title_full_unstemmed Proton therapy versus photon radiation therapy for the management of a recurrent desmoid tumor of the right flank: a case report
title_short Proton therapy versus photon radiation therapy for the management of a recurrent desmoid tumor of the right flank: a case report
title_sort proton therapy versus photon radiation therapy for the management of a recurrent desmoid tumor of the right flank: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3542192/
https://www.ncbi.nlm.nih.gov/pubmed/23098082
http://dx.doi.org/10.1186/1748-717X-7-178
work_keys_str_mv AT kilwhoonjong protontherapyversusphotonradiationtherapyforthemanagementofarecurrentdesmoidtumoroftherightflankacasereport
AT nicholsrcharles protontherapyversusphotonradiationtherapyforthemanagementofarecurrentdesmoidtumoroftherightflankacasereport
AT kilkennyjohnw protontherapyversusphotonradiationtherapyforthemanagementofarecurrentdesmoidtumoroftherightflankacasereport
AT huhsoony protontherapyversusphotonradiationtherapyforthemanagementofarecurrentdesmoidtumoroftherightflankacasereport
AT homengwei protontherapyversusphotonradiationtherapyforthemanagementofarecurrentdesmoidtumoroftherightflankacasereport
AT guptapratibha protontherapyversusphotonradiationtherapyforthemanagementofarecurrentdesmoidtumoroftherightflankacasereport
AT marcusrobertb protontherapyversusphotonradiationtherapyforthemanagementofarecurrentdesmoidtumoroftherightflankacasereport
AT indelicatodanielj protontherapyversusphotonradiationtherapyforthemanagementofarecurrentdesmoidtumoroftherightflankacasereport